Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
2000 · Breast Cancer Research · 0 citations
https://doi.org/10.1186/bcr123